Skip to content

ORIC - Oric Pharmaceuticals, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchO

Oric Pharmaceuticals Inc

ORIC · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

O

ORICOric Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $14.93
52-wk low: $7.23
Prev close: $10.86
Mkt cap: $1.52B
Beta: 0.97
P/B: 3.8x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$291.8M

VG
Viking Global
Andreas Halvorsen · Q2 2026 13F
$55.5M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.5B

Valuation

P/B3.79

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ORIC
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.52B
Beta: 0.97

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-39.8%

$28.1M

position

P7

Point72

Steven Cohen · Q4 2025 13F

$23.9M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ORIC

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

EPS expected

-$0.38

-$0.45 to -$0.32

Revenue expected

$0.00

13 analysts

Last 30 days

1up6down

Analysts cutting estimates

Estimate drift

0.01

Change in 30 days

-39.8%

ROA-26.0%

Growth

Beta0.97